Oct 22, 2025 7:30am EDT ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
Sep 23, 2025 8:00am EDT PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE
Sep 12, 2025 8:00am EDT ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor
Sep 03, 2025 8:00am EDT ProPhase Labs Inc. to Participate in Renmark’s Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025
Aug 19, 2025 8:00am EDT ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders
Aug 13, 2025 8:00am EDT ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025
Aug 12, 2025 8:00am EDT ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
